CAR-T CELL THERAPY
Clinical trials for CAR-T CELL THERAPY explained in plain language.
Never miss a new study
Get alerted when new CAR-T CELL THERAPY trials appear
Sign up with your email to follow new studies for CAR-T CELL THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on hard-to-treat lymphoma
Disease control Recruiting nowThis study tests a new treatment called zamtocabtagene autoleucel (MB-CART2019.1) for people with diffuse large B cell lymphoma that has come back or not responded to at least two prior treatments. The therapy uses a patient's own immune cells, which are genetically modified to r…
Matched conditions: CAR-T CELL THERAPY
Phase: PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Jun 17, 2026 07:54 UTC
-
New CAR-T therapy targets tough lung cancer in early trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called TC-D101 for people with a specific type of advanced small cell lung cancer that has not responded to standard therapies. The treatment uses the patient's own immune cells, modified to attack cancer cells carrying a protein calle…
Matched conditions: CAR-T CELL THERAPY
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New CAR-T therapy targets tough leukemia in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called A-CAR028 for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses specially engineered immune cells (CAR-T cells) to attack the cancer. The main goals are to check …
Matched conditions: CAR-T CELL THERAPY
Phase: PHASE1 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Engineered immune cells take on aggressive MS in early trial
Disease control Recruiting nowThis study tests a new treatment called MB-CART2019.1 for people with active multiple sclerosis (MS) that hasn't responded to other therapies. The treatment uses a patient's own immune cells, modified to target and attack harmful immune cells driving MS. The goal is to see if it …
Matched conditions: CAR-T CELL THERAPY
Phase: PHASE1, PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
Engineered immune cells take aim at stubborn lupus
Disease control Recruiting nowThis early-phase trial tests a new treatment called GC012F (CD19-BCMA CAR-T cells) for people with systemic lupus erythematosus (SLE) that hasn't improved with standard therapies. About 18 adults aged 18-70 with active lupus will receive a single infusion of these specially engin…
Matched conditions: CAR-T CELL THERAPY
Phase: EARLY_PHASE1 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC
-
Food bags for transplant patients: a recipe for better recovery?
Disease control Recruiting nowThis study looks at whether providing free bags of groceries to patients undergoing stem cell transplants or CAR-T cell therapy can help improve their nutrition and treatment results. Many patients face high medical costs that make it hard to afford enough food, which can hurt th…
Matched conditions: CAR-T CELL THERAPY
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC
-
New app aims to ease CAR-T journey for cancer patients
Symptom relief Recruiting nowThis study tests a mobile app called THRIVE-CAR-T designed to support patients during CAR-T cell therapy. Researchers want to see if the app is easy to use and acceptable to patients. About 100 adults with blood cancer receiving CAR-T treatment will participate. The app provides …
Matched conditions: CAR-T CELL THERAPY
Phase: NA • Sponsor: Patrick C. Johnson, MD • Aim: Symptom relief
Last updated Jun 15, 2026 19:06 UTC
-
New program helps transplant survivors walk farther and feel stronger
Symptom relief Recruiting nowThis study tests a program that combines in-person coaching with a smartphone app to help people who have had a stem cell transplant or CAR-T therapy cope with pain, fatigue, and stress. The goal is to help them become more active and reduce physical disability. About 177 adults …
Matched conditions: CAR-T CELL THERAPY
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 15, 2026 18:56 UTC
-
New study aims to predict brain complications from cancer treatment
Knowledge-focused Recruiting nowThis study looks at why some people getting CAR T-cell therapy for cancer develop brain-related side effects (neurotoxicity). Researchers will use brain scans, thinking tests, and blood tests to find early warning signs. The goal is to create a tool that can predict these side ef…
Matched conditions: CAR-T CELL THERAPY
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC